To evaluate the effects of bisphenol A (BPA), a candidate endocrine disruptor (ED), on embryonic development, we examined the mRNA expression levels of the aryl hydrocarbon receptor (AhR; which binds with many EDs and plays crucial roles in their metabolism) and related factors [aryl hydrocarbon receptor repressor (AhRR) and AhR nuclear translocator (Arnt)], xenobiotic metabolizing enzymes [XMEs; cytochrome P450 1A1 (CYP1A1) and UDP-glucuronosyltransferase, and the glutathione S-transferase Ya subunit (GST)], in murine embryos exposed in utero to BPA (0.02, 2, 200, and 20,000 µg/kg/day) and 17β-estradiol (E2; 5 µg/kg/day, used as a positive control) at 6.5-13.5 or 6.5-17.5 days post coitum (dpc) using the quantitative real-time reverse transcriptionpolymerase chain reaction (RT-PCR) method. Protein levels of CYP1A1 and GST in embryonic livers were estimated by Western immunoblotting. Exposure in utero to BPA [0.02 (1/100 dose of environmental exposure), 2, 200, and 20,000 µg/kg/day] increased AhR mRNA expression in the cerebra, cerebella, and gonads (testes and ovaries) of male and female mid-and late-developmental stage (14.5-and 18.5-dpc, respectively) embryos. BPA dose-independently up-regulated the expression of AhRR and Arnt in mid-and late-stage embryos. BPA had no remarkable effect on the mRNA levels of XMEs in mid-stage embryos, but dose-dependently up-regulated the expression in late-stage embryos. Moreover, the protein levels of these enzymes in the livers of late-stage embryos were increased. The present findings revealed that exposure to BPA in utero disrupts the expression of AhR and related factors and of xenobiotic metabolizing enzymes, and that mid-stage embryos, in the organogenic stage, are sensitive to BPA. Key words: Aryl hydrocarbon receptor (AhR), AhR relating factor, Bisphenol A (BPA), Murine embryo, Xenobiotic metabolizing enzymes (XMEs) (J. Reprod. Dev. 51: [593][594][595][596][597][598][599][600][601][602][603][604][605] 2005) isphenol A [BPA; 2,2-bis (4-hydroxyphenyl) propane], which is composed of two benzene rings and in conformation resembles a synthetic estrogen, diethylstilbestrol (DES), is a common plasticizer for polycarbonate and epoxy resins and a candidate environmental endocrine disruptor (ED) [1, 2] . BPA has toxicological effects on the reproductive, immunological, and nervous systems in mammals, binds with estrogen receptor-α (ERα; NR3A1) and ER-β (NR3A2), and induces estrogenic activity [3] [4] [5] [6] . BPA affects the expression levels of ERs and ER-like nuclear receptor mRNAs in the rat uterus [6] , but the mechanism of its actions has yet
to be elucidated. A weak estrogenic action for BPA was confirmed by an approximately 1/15,000 lower affinity for ERα than E2, endogenous estrogen, estimated using a yeast-based steroid hormone receptor gene transcription assay [7] . When pregnant mice orally received a low-dose of BPA (2.4 µg/kg/day; equal dose to environmental exposure [8] ) during the organogenic period, the span of the vaginal opening and first vaginal estrus in female offspring was significantly reduced [9] . To evaluate the effects of BPA on embryonic development, we previously determined the mRNA levels of retinoid receptors [retinoic acid receptor-α (RARα; NR1AB) and retinoid X receptor-α (RXRα; NR2B1)] in murine embryos that were exposed in utero to BPA (0.02, 2, 200, and 20,000 µg/kg/day) at 6.5-17.5 days post-coitum (dpc) using the quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) method, and confirmed the following [10] : RARα and RXRα mRNAs were expressed in the cerebra, cerebella, and gonads (testes and ovaries) of male and female murine embryos from 12.5 to 18.5 dpc. Exposure to BPA in utero disrupted the expression of RARα and RXRα mRNAs in cerebra and c e r e b e l l a o f m a l e a n d f e m a l e e m b r y o s . Interestingly, an extremely low dose of BPA (0.02 µg/kg/day; 1/100 the level received from environmental exposure) significantly increased RARα mRNA expression in the cerebella of male and female 14.5-and 18.5-dpc-embryos and in the g o n a d s o f f e m a l e 1 4 . 5 -d p c -e m b r y o s , a n d significantly increased RXRα mRNA expression in the cerebra and cerebella of male and female 14.5-dpc-embryos. These results indicate that exposure to a low dose of BPA in utero affects the levels of RARα and RXRα mRNAs in murine embryos, and BPA disrupts sex differentiation and gonadal development by disrupting the expression of RARα and RXRα.
The aryl hydrocarbon receptor (AhR) mediates the toxicological effects of polycyclic aromatic hydrocarbons (PAHs), a family of toxic compounds that includes 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polychlorinated biphenyls, and polycyclic aromatic hydrocarbons [11] [12] [13] [14] [15] [16] [17] [18] . The major toxic effects of PAHs, mainly TCDD, are mediated by AhR, which has high binding affinity for PAHs. In the absence of a ligand, AhR exists in a cytoplasmic complex with 3 partner molecules [heat shock protein 90 (H sp90), co -chaperon p23, and immunophilin-like protein XAP2/AIP/ARA9]. When ligand/compound binds with AhR, ligandAhR replaces its partner Hsp90-p23-XAP2-complex with the AhR nuclear translocator (Arnt), and then translocates into the nucleus. In the nucleus, the AhR-Arnt heterodimeric complex binds with a specific DNA sequence designated XRE/DRE/ AhRE (the core consensus sequence is 5'-TNG CGT G-3') in the promoter region of target genes, and enhances the transcription of these genes. Some of the target genes encode xenobiotic metabolizing enzymes [XMEs; cytochrome P450 1A1 (CYP1A1: a typical XME induced by PAHs9), CYP1A2, CYP1B1, UDP-glucuronosyltransferase, the glutathione S-transferase Ya subunit (GST), quinone oxidoreductase, nicotinamide adenine dinucleotide phosphate-oxidoreductase, and so on] [19, 20] . Aryl hydrocarbon receptor repressor (AhRR), which dimerizes with Arnt protein and competes with AhR to bind XRE, is also induced by the AhR-Arnt heterodimeric complex, plays a key role in the negative feedback mechanism, and d o w n -r e g u l a t e s t h e A h R -m e d i a t e d g e n e expression [21] . It remains to be elucidated how AhR is involved in TCDD-induced toxicobiological effects, such as teratogenesis and immunsuppression. It is considered that the toxic effects of TCDD are caused by the expression of specific genes induced by ligand-binding/activated AhR. AhR-knockout (KO) mice were resistant to the acute toxicity of TCDD, but had an alternated teratogenic response to TCDD [22] [23] [24] . The embryos and adults had a number of abnormal phenotypes and were defective in the development of liver and immune systems. AhR-KO mice showed vitamin A/retinoid accumulation in the liver and an abnormal morphology in the liver and kidneys, thus confirming that AhR plays important roles in embryonic morphogenesis. Among the most consistent phenotypes of AhR-KO mice, an abnormal vascular structure in the liver is considered to be associated with accelerated rates of hepatocyte apoptosis. Pathogenic findings suggested that accelerated rates of apoptosis may be related to an abnormal accumulation of retinoic acid in hepatocytes, and such an accumulation causes a hyper-activation of transforming growth factor-β1, resulting in higher rates of hepatocyte apoptosis [24] .
In the preimplantation embryos of normal mice, the mRNA and protein of AhR, which regulates the levels of CYPs responsible for the metabolism of retinoic acid, were detected and had marked effects on embryogenesis (cell proliferation, growth, differentiation, and death) [25] [26] [27] [28] . The oxidative conversion of all-trans-retinol (t-ROH) to t-retinal (t-RAL) is the rate-limiting step in the biosynthesis of t-RA from t-ROH in mammalian tissues [26] . CYP1A1 and CYP1B1 play important roles in the biosynthesis of t-RA from t-ROH. CYP1A2 and CYP3A4 are the major cytochrome P450 enzymes catalyzing the oxidative conversion of t-ROH to t-RAL. In addition, CYP1A1, UDP-glucuronosyltransferase, and GST play crucial roles in the metabolism of xenobiotic compounds. In adult rats, approximately 60% of orally ingested BPA was rapidly absorbed by the small intestine, transfered to the liver, and metabolized by enzymes such as CYP1A1, UDP-glucuronosyltransferase, and GST, within 60 min [29, 30] . However, UDP-glucuronosyltransferase and GST levels were extremely low, and the activity levels of these enzymes, which were assessed biochemically using xenoestrogens as a substrate, were increased during growth in neonatal rats [31] . Thus, AhR is not only a key receptor in xenobiotic metabolism but also a crucial r e c e p t o r m e d i a t i n g e m b r y o g e n e s i s a n d teratogenesis. AhR protein is expressed in most organs of adult mice [32, 33] and in the livers of murine embryos at 9.5-dpc [34, 35] . However, the changes in the expression of AhR mRNA in murine embryos during embryogenesis have yet to be demonstrated. In the present study, to evaluate the effects of BPA on metabolism of xenobiotic compounds in murine embryos (from mid-to latestages), we examined the mRNA levels of AhR, AhRR, Arnt, CYP1A1, and GST in the cerebra, cerebella, and gonads of murine embryos using the quantitative real-time reverse transcriptionpolymerase chain reaction (RT-PCR) technique. In addition, changes in the protein levels of CYP1A1 and GST in embryonic livers were examined by Western immunoblotting.
Materials and Methods

Preparation of embryonic tissue
Male and female ICR mice (Clea Japan, Tokyo, Japan) were housed under controlled temperature (24 ± 2 C), lighting (12 h light: 12 h darkness), and humidity (75 ± 5%), and given a standard diet (CM; Oriental Yeast, Tokyo, Japan) and tap water ad libitum. They received humane care as outlined in the "Guide for the Care and Use of Laboratory A n i m a ls " ( K y o t o U n i v e r s i ty A n i m al C a r e Committee according to NIH No. 86-23; revised 1999). After mating, females found to have a vaginal plug were considered to be at 0.5 dpc. To d e t e r m i n e t h e e f f e c t s o f B P A ( W a k o P u r e Chemicals, Osaka, Japan), pregnant mice were orally administered BPA (0.02, 2, 200, or 20,000 µg/ kg/day; dissolved in olive oil) and E2 (5 µg/kg/ day dissolved in olive oil; Wako). These doses were based on our previous studies [12, 36, 37] . The oral administration was performed in the afternoon (12:00 to 14:00) from 6.5 to 13.5, and 6.5 to 17.5 dpc (8 and 12 times, respectively). Vehicle controls were orally treated with purified olive oil (5 ml/kg) under the same conditions. Pregnant mice were sacrificed at 14.5 and 18.5 dpc (n=12/each group) under anesthesia with diethyl ether (Wako) 24 h after the last administration of BPA. The embryos were rapidly removed, weighed, and dissected. For quantitative real-time RT-PCR and Western immunoblot analysis, the cerebrum, cerebellum, gonads (ovaries and testes), and liver of male and female embryos were frozen and kept in liquid nitrogen prior to use.
Quantitative real-time RT-PCR analysis
Quantitative real-time RT-PCR analysis was performed according to our previous reports [12, 37, 38] . Briefly, total RNA was extracted from each embryonic organ using a RNeasy Mini Kit (Qiagen, Valencia, CA, U.S.A.), and then 1 µg/organ of the total RNA was reverse-transcribed with an oligo(dT) primer using a T-primed First-Strand Kit (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.) to synthesize the first strand cDNA. The cDNA was quick-chilled on ice to denature the RNA-cDNA duplex. mRNA levels of AhR, RARα, R X R α , a n d g l y c e r a l d e h y d e s -3 -p h o s p h a t e dehydrogenase (GAPDH; used as an intrinsic control) were quantified using a LightCycler 
Additionally, to determine the sex of each embryo, genomic DNA samples were prepared from the liver using a Miniprep Kit (Qiagen), and then PCR for the Y chromosome Sry gene was performed according to McClive and Sinclair [39] . The Sry gene in each sample was amplified using the following primer pair: forward: 5'-TCATG AGACT GCCAA CCACA G-3', and reverse: 5'-CATGA CCACC ACCAC CACCA A-3'. The hot-start PCR profile was as follows: 95 C for 10 min, then 45 cycles of 95 C for 15 sec, 57 C for 5 sec, 72 C for 8 sec, a n d a f i n a l e x t e n s i o n a t 6 2 C f o r 1 0 s e c . Quantification was performed using Light-Cycler analysis software (Roche) on an IBM compatible computer (Hewlett-Packard, Palo Alto, CA, U.S.A.). The relative abundance of specific mRNA was normalized to the relative abundance of GAPDH mRNA. The DNA sequence of each PCR product was determined with an automatic DNA sequencer (ABI Prism 310; PE Applied Biosystems, F o s t e r C i t y , C A , U . S . A . ) a c c o r d i n g t o t h e manufacturer's directions, and then the expression of AhR, Arnt, AhRR, CYP1A1, and GST mRNAs was confirmed.
Western immunoblotting
Each frozen liver sample prepared from an embryo was homogenized in PBS containing a protease inhibitor mixture (Sigma-Aldrich Co., St. 
Statistical analysis
ANOVA for the real-time RT-PCR and Western immunoblot data was carried out using the StatView-4.5 program (Abcam, Cambridge, UK) on a Macintosh computer. Differences of P<0.05 were considered significant.
Results
Changes in levels of AhR mRNA in embryonic organs
We summarized the effects of exposure to BPA in utero on the expression levels of AhR mRNA in the cerebra (Fig. 1A and B) , cerebella ( Fig. 1C and D) , and gonads (testes and ovaries; Fig. 1E and F ) of 14.5- (Fig. 1A, C , and E) and 18.5-dpc-embryos (Fig.  1B, D, and F) . The exposure remarkably increased AhR mRNA expression in the cerebra, cerebella, and gonads of both male and female 14.5-and 18.5-dpc-embryos. Interestingly, an extremely low dose of BPA (0.02 µg/kg/day; which is less than 1/100 the dose received from environmental exposure) had strong effects on the levels of AhR mRNA as follows: In the cerebra of male and female embryos at 14.5 dpc, exposure to BPA up-regulated the AhR mRNA expression (Fig. 1A) . In the cerebra of 18.5-dpc-embryos (Fig. 1B) , BPA (0.02, 200, and 20,000 µg/kg/day) markedly increased the levels of AhR mRNA (more than 50-fold; P<0.001). In the cerebella of 14.5-and 18.5-dpc-embryos (Fig. 1C and D, respectively), exposure to extremely low (0.02 µg/kg/day) and high (200 and 20,000 µg/kg/ day, respectively) doses of BPA up-regulated the expression of AhR mRNA (40-to 80-fold; P<0.01 and 0.001). In the gonads of 14.5-dpc-embryos (Fig. 1E ), exposure to extremely low-and high-doses of BPA (0.02 and 20,000 µg/kg/day, respectively) markedly increased the AhR mRNA expression (more than 30-and 70-fold; P<0.01 and 0.001), and 2 and 200 µg/kg/day of BPA also increased the expression. AhR mRNA expression showed a diphasic (U) dose-response curve following exposure to BPA. In the gonads of 18.5-dpcembryos (Fig. 1F) , exposure to BPA, except at 20,000 µg/kg/day, increased the expression levels of AhR mRNA (P<0.01).
Changes in levels of AhRR mRNA in embryonic organs
In Fig. 2 , we summarized the effects of exposure to BPA in utero on the expression of AhR mRNA in the cerebra ( Fig. 2A and B) , cerebella ( Fig. 2C and  D) , and gonads (testes and ovaries; Fig. 2E and F ) of 14.5-( Fig. 2 ; A, C, and E) and 18.5-dpc-embryos (Fig. 2B, D, and F) . In the cerebra and cerebella of male and female 14.5-and 18.5-dpc-embryos, an extremely low dose of BPA (0.02 µg/kg/day) had a strong up-regulating effect on the expression of AhRR mRNA. In the cerebra and cerebella of male and female 14.5-dpc embryos, 0.02 µg/kg/day significantly increased the levels of AhRR mRNA and this increase was larger than in higher doses of BPA (200 and 20,000 µg/kg/day) (P<0.05 and 0.01).
At 18.5 dpc (Fig. 2B and D) , extremely low and high doses of BPA (0.02 and 20,000 µg/kg/day, respectively) significantly up-regulated the expression of AhRR mRNA (P<0.01 and 0.001, respectively). In the cerebra and cerebella of 14.5-and 18.5-dpc-embryos, however, E2 had no remarkable effect. At 18.5 dpc, extremely low-and high-doses of BPA (0.02 and 20,000 µg/kg/day) and E2 up-regulated the expression of AhRR mRNA (more than 10-fold; P<0.01 or 0.001).
Changes in levels of Arnt mRNA in embryonic organs
The effects of exposure to BPA in utero on the expression of AhR mRNA in the cerebra (Fig. 3A  and B) , cerebella ( Fig. 3C and D) , and gonads (testes and ovaries; Fig. 3E and F ) of 14.5- (Fig. 3A, C , and E) and 18.5-dpc-embryos (Fig. 3B, D, and F) are summarized in Fig. 3 . In the cerebra and cerebella of male and female 14.5-and 18.5-dpc-embryos, BPA, except at 2 µg/kg/day, increased the level of Arnt mRNA. BPA and E2 had no effect in gonads of 14.5-dpc-embryos (Fig. 3E) , but an extremely low dose of BPA (0.02 µg/kg/day) markedly upregulated the expression of Arnt mRNA in the gonads of 18.5-dpc-embryos ( Fig. 3F; P<0 .05 and 0.01).
Changes in levels of CYP1A1 mRNA in embryonic organs
The effects of exposure to BPA in utero on the expression of CYP1A1 mRNA in the cerebra (Fig.   Fig. 2 . Changes in levels of AhRR mRNA in the cerebra (A and B), cerebella (C and D), and gonads (testes and ovaries: E and F) of 14.5-(A, C, and E) and 18. 4A and B), cerebella ( Fig. 4C and D) , and gonads (testes and ovaries; Fig. 4E and F ) of 14.5- (Fig. 4A , C, and E) and 18.5-dpc-embryos (Fig. 4B, D , and F) are summarized in Fig. 4 . In all tissues of control male and female 14.5-and 18.5-dpc-embryos, only trace levels of CYP1A1 mRNA expression were detected. In the cerebra and cerebella of 18.5-dpcembryos ( Fig. 4B and D) , BPA dose-dependently up-regulated the expression of CYP1A1 mRNA.
Changes in levels of GST mRNA in embryonic organs
The effects of exposure to BPA in utero on the expression of GST mRNA in the cerebra (Fig. 5A and B), cerebella ( Fig. 5C and D) , and gonads (testes and ovaries; Fig. 5E and F) of 14.5- (Fig. 5A, C , and E) and 18.5-dpc-embryos (Fig. 5B, D, and F) are summarized in Fig. 5 . In all tissues of control male and female 14.5-and 18.5-dpc-embryos, only trace levels of GST mRNA were detected. In the cerebra and cerebella of 14.5-dpc-embryos ( Fig. 5A and C) , E2 increased the expression of GST mRNA (P<0.05). In the cerebra and cerebella of 18.5-dpcembryos ( Fig. 5B and D) , BPA dose-dependently increased the GST mRNA levels. In the gonads of 18.5-dpc-embryos (Fig. 5F ), BPA (200 and 20,000 µg/kg/day) and E2 remarkably increased the expression (P<0.01). 
Changes in protein levels of CYP1A1 and GST in embryonic livers
The effects of exposure to BPA in utero on the protein levels of CYP1A1 and GST in the livers of 18.5-dpc-embryos are summarized in Fig. 6 . An extremely low dose of BPA (0.02 µg/kg/day) had no effect on the protein level of CYP1A1 or GST, but higher doses (2 and 200 µg/kg/day) of BPA increased both levels (P<0.05). An extremely high dose of BPA (20,000 µg/kg/day) and E2 markedly enhanced the levels (P<0.01). In the livers of 14.5-dpc-embryos, these proteins were not detectable by Western immunoblotting (data not shown).
Discussion
BPA exhibits an estrogenic activity by binding to estrogen and/or androgen receptor(s) [5] [6] [7] [8] . A weak estrogenic action of BPA was confirmed by an approximately 1/15,000 lower affinity for ERα than E2 [9] . When pregnant mice received BPA (2.4 µg/ kg/day), sexual maturation in female offspring significantly decreased [11] . An in vitro study [40] using early-stage embryos of mice showed that BPA (at concentrations of 1 and 3 nM) had stimulatory effects on blastocyst formation, but 100 µM BPA was inhibitory, indicating BPA has bifocal effects on embryogenesis. In adult ovariectomized rats, oral administration of BPA (100-10,000 µg/ k g / d a y ) d o s e -d e p e n d e n t l y i n c r e a s e d t h e expression of the progesterone receptor in hypothalamus cells and affected sexual behavior [41] . Because the effects of exposure to BPA (2 µg/ kg/day) in utero on embryonic development have not been reported yet, we previously showed that higher mRNA levels of RARα and RXRα, factors essential for embryogenesis in mammals [27, 28, [42] [43] [44] , were detected in the cerebra and cerebella of murine embryos at 12.5, 14.5, 16.5, and 18.5 dpc by a quantitative real-time RT-PCR method. An extremely low dose of BPA (0.02 µg/kg/day) significantly increased levels of RARα mRNA in the cerebella of male and female 14.5-and 18.5-dpcembryos and in the ovaries of 14.5-dpc-embryos [12] . The mRNA levels of RARα and RXRα are sensitive parameters with which to assess the toxic effects of BPA on embryogenesis. The classical endocrine disrupting mechanism of BPA is considered to be as follows: BPA acts as an antagonist of estrogen and binds with ERs. In this paper, we propose a novel endocrine disrupting mechanism, whereby BPA up-regulates the mRNA expression of AhR.
AhR binds with xenobiotic compounds, such as TCDD, and then mediates their toxic effects [16] . Moreover, AhR acts as an inducer of XMEs, and so enhances the metabolism of xenobiotic compounds [29, 30] . To date, the effects of BPA on the metabolism of xenobiotic compounds mediated by AhR during the development of mammalian embryos have not been reported. Furthermore, detailed studies on the expression patterns of AhR a n d r e l a t e d f a c t o r s , o n X M E s d u r i n g embryogenesis, and on the effects of exposure to BPA in utero on the expression levels of these factors have not been conducted. In the present study, to determine the effects of BPA on the metabolism of xenobiotic compounds, we examined the expression patterns of AhR and related factors, and of XMEs in murine embryos exposed to BPA in utero. We demonstrated that the exposure up-regulated the expression of AhR, AhRR, Arnt, CYP1A1, and GST mRNAs in the cerebra, cerebella, and gonads of male and female 14.5-and 18.5-dpc-embryos. In all tissues of 14.5-and 18.5-dpc-embryos, BPA dose-independently increased the AhR mRNA levels. Interestingly, an extremely low dose of BPA (0.02 µg/kg/day) remarkably increased the expression of AhR mRNA in the cerebra, cerebella, and gonads of male and female 14.5-and 18.5-dpc-embryos. In the same low dose treatment group, high levels of AhRR and Arnt mRNAs were also noted. BPA upregulated the mRNA expression of XMEs (CYP1A1 and GST) in the cerebra, cerebella, and gonads of the mid-developmental stage (14.5-dpc) embryos, but had no effect on the late-developmental stage (18.5-dpc) embryos. However, protein levels of these enzymes in the livers of 14.5-dpc-embryos were extremely low (not detectable by Western i m m u n o b l o t t i n g ) , a n d B P A i n c r e a s e d t h e expression of these enzymes in 18.5-dpc-embryos. These findings indicate that a low dose of BPA (less than or equal to environmental levels of exposure) can disrupt the AhR-mediated metabolism of xenobiotic compounds in embryonic organs, but BPA has no effect on the protein levels of XMEs in the livers of embryos. Because metabolic enzyme levels in embryonic livers are extremely low, BPA may accumulate in the organs of mid-stage embryos. These metabolic enzymes are catalyzers for the metabolites of exogenous and endogenous estrogen(s) [45] , and so we speculate that BPA d i s r u p t s t h e e s t r o g e n -d e p e n d e n t s i g n a l transducing system not only via the direct interruption of ER expression [46, 47] , but also through the indirect disruption of estrogen catabolic-metabolism.
The AhR/Arnt heterodimer directly associates with ERs and estrogen-responsive gene promoters are activated [48] . Such activation up-regulates the transcription and enhances the estrogenic effects. BPA increased the expression of both AhR and Arnt mRNAs, suggesting that ER-mediated estrogenic effects may be promoted by BPA. Furthermore, the estrogenic activity of BPA is increased after co-incubation with the liver to c a t a b o l i z e t h e B P A , i n d i c a t i n g t h a t B P A metabolite(s) may have a higher estrogenic potency than the mother compound [49] [50] [51] . We suggest that BPA itself plays a key role in the estrogenic activity of mid-stage embryos because activity for drug-metabolism in embryonic livers is extremely weak. We also suggest that both BPA and its active metabolite(s) strongly disrupt the estrogenic signals in late-stage embryos because drugmetabolism in the embryonic liver is induced by exposure to BPA.
In conclusion, this is the first paper to confirm the quantitative changes in the mRNA levels of AhR and related factors, AhRR and Arnt, and AhRmediated drug-metabolic enzymes, CYP1A1 and GST, as assessed by the quantitative RT-PCR method in embryonic organs (cerebra, cerebella, testes, and ovaries) during the mid-to late-stages of embryonic development. We confirmed that exposure to an extremely low dose of BPA (0.02 µg/kg/day) in utero increased the levels of these mRNAs in embryos. Futhermore, we proposed a novel mechanism of BPA-mediated endocrine disruption in which BPA up-regulates the mRNA expression of AhR and related factors. Nuclear receptors, such as AhR, are major targets of xenobiotic compounds and play crucial roles in embryonic development [52] . The present findings, moreover, contribute to the assessment of the toxic effects of EDs on embryogenesis.
